FUJIFILM Diosynth Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- FUJIFILM Diosynth Biotechnologies's estimated annual revenue is currently $830.2M per year.
- FUJIFILM Diosynth Biotechnologies's estimated revenue per employee is $155,000
Employee Data
- FUJIFILM Diosynth Biotechnologies has 5356 Employees.
- FUJIFILM Diosynth Biotechnologies grew their employee count by 8% last year.
FUJIFILM Diosynth Biotechnologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Quality Operations | Reveal Email/Phone |
2 | Head Biologics Program Management, Billingham | Reveal Email/Phone |
3 | Head Platform Operations Group (Saturn R&D) | Reveal Email/Phone |
4 | Head Quality, MCC | Reveal Email/Phone |
5 | Head Late Phase Mircrobial Programme Management | Reveal Email/Phone |
6 | Head People and Culture, FDBC | Reveal Email/Phone |
7 | Head Upstream Process Science | Reveal Email/Phone |
8 | Head Program Operations | Reveal Email/Phone |
9 | Head Operational and Business Excellence | Reveal Email/Phone |
10 | Head Customer Experience | Reveal Email/Phone |
FUJIFILM Diosynth Biotechnologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 101 | 5% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 470 | 16% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5356 | 8% | N/A | N/A |
What Is FUJIFILM Diosynth Biotechnologies?
As a CDMO our focus is to combine technical leadership in cell culture, microbial fermentation and viral vectors with world class cGMP manufacturing facilities to advance tomorrow's medicines. For over 25 years our focus has been on supporting our customers with the development and manufacture of recombinant proteins, viral vaccines and gene therapies. Our Competencies and Capabilities: Expertise with products expressed in a wide range of expression platforms including: microbial fermentation (e.g., E. coli, P. pastoris), cell culture systems including CHO , HEK, Vero, MDCK, EB66 and insect cells, and transgenics. Extensive viral vector experience, including the process development, scale up and cGMP production of: Adenovirus, Adeno-associated virus (AAV), Lentivirus, Poxvirus and Baculovirus among others. In-house developed Microbial (pAVEway) and mammalian (Apollo) expression platforms Cell banking capabilities Full life-cycle biological and viral products manufacturing from initial concept to commercial product Analytical and Formulation Development Services for biologics, vaccines and advanced therapies Expertise in Process Characterization Studies with over 44 programs completed Our cGMP Manufacturing Capabilities Cell Culture cGMP Manufacturing Capabilities ranging from 100L to multiple 2,000L Microbial Fermentation Manufacturing cGMP Capabilities ranging from 100L to multiple 5,000L. 20,000L large scale microbial production in collaboration with MSD Low dose biologics cGMP Manufacturing capabilities Gene Therapy and viral vector cGMP manufacturing facilities supporting production from pre-clinical to commercial production
keywords:Biotechnology,Healthcare,Pharmaceuticals
N/A
Total Funding
5356
Number of Employees
$830.2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
FUJIFILM Diosynth Biotechnologies News
FUJIFILM Diosynth Biotechnologies has over thirty years of experience in the development and manufacturing of recombinant proteins, vaccines,...
Chimeron Bio selected FUJIFILM Diosynth Biotechnologies as its partner for the transfer and scale up of their drug substance manufacturing...
FUJIFILM Diosynth Biotechnologies will run the cell therapy manufacturing facility, acquired for $100mn from Atara Biotherapeutics,...